SPA
ACH

Sherbrooke Park Advisers’s Accendra Health ACH Stock Holding History

Sherbrooke Park Advisers’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-42,239
Closed -$570K – 1154
2024
Q2 		$570K Buy
+42,239
New +$865K 0.1% 357

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sherbrooke Park Advisers's ACH Position: Q3 2024 in Review

Sherbrooke Park Advisers sold out of Accendra Health (ACH) in Q3 2024, closing a stake of 42,239 shares — an estimated $570K sold.

Sherbrooke Park Advisers first reported a position in ACH in Q2 2024 and held it in 1 quarter. The position peaked at $570K in Q2 2024. 214 funds tracked by Wall St. Rank hold ACH as of Q3 2024.

  • Sherbrooke Park Advisers reported no remaining Accendra Health position as of Q3 2024 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 42,239 Accendra Health shares in Q3 2024, an estimated $570K.
  • Sherbrooke Park Advisers first reported a position in Accendra Health in Q2 2024 and held it in 1 quarter.
  • Sherbrooke Park Advisers's Accendra Health position peaked at $570K in Q2 2024.
  • 214 funds tracked by Wall St. Rank held Accendra Health as of Q3 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.